[ad_1]
Johnson & Johnson has reported “more than a billion dollars. transaction for an experimental vaccine against the SARS-CoV-2 coronavirus for $ 100 million. doses to the United States, subject to approval or approval by the United States Food and Drug Administration (FDA) in emergencies.
Unlike other companies, Johnson & Johnson has not disclosed the exact amount it will receive from US authorities under the terms of the deal, but its vaccine dose is likely to cost about $ 10, Barron’s writes.
Previously, European pharmaceutical manufacturers Sanofi and GlaxoSmithKline announced around $ 2.1 billion. $ 100 million settlement with the United States government. doses of its vaccine sales. A similar agreement worth 1,950 million. Pfizer Inc. and BioNTech.
Johnson & Johnson launched the first clinical trials of its COVID-19 vaccine in late July.
[ad_2]
